Published in Cardiovasc Toxicol on January 05, 2008
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 14.48
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Structure and function of intercellular junctions. Int Rev Cytol (1974) 8.14
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 6.30
Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A (1990) 5.83
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82
Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A (1995) 5.54
Cardiac malformation in neonatal mice lacking connexin43. Science (1995) 5.51
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev (2003) 4.87
A core function for p120-catenin in cadherin turnover. J Cell Biol (2003) 4.85
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med (2004) 4.59
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res (2001) 4.38
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Gap junction structures. II. Analysis of the x-ray diffraction data. J Cell Biol (1977) 3.95
Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol (2000) 3.88
Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res (2003) 3.84
Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg (2002) 3.62
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res (2002) 3.52
Developmental defects in mouse embryos lacking N-cadherin. Dev Biol (1997) 3.39
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res (2002) 3.10
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res (2005) 3.03
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Cardiac regeneration: repopulating the heart. Annu Rev Physiol (2006) 2.92
Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res (2007) 2.74
Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol (1997) 2.65
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Stem cell differentiation requires a paracrine pathway in the heart. FASEB J (2002) 2.55
Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation (2003) 2.54
Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res (2005) 2.44
Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res (2005) 2.44
Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res (2005) 2.44
Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res (2007) 2.38
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg (2005) 2.35
Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol (2005) 2.34
Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev Biol (2003) 2.27
Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation (2006) 2.26
Cell-based cardiac repair: reflections at the 10-year point. Circulation (2005) 2.25
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation (2004) 2.23
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol (1998) 2.14
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J (2007) 2.10
Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells (2005) 2.06
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol (2003) 2.05
Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res (2006) 2.02
Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation (2007) 2.02
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med (2007) 1.97
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng (2000) 1.96
Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol (2007) 1.92
Stem cell-derived cardiomyocytes demonstrate arrhythmic potential. Circulation (2002) 1.90
Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol (2007) 1.87
Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 1.86
Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest (1997) 1.83
Endogenous cardiac stem cells. Prog Cardiovasc Dis (2007) 1.79
Electrophysiological maturation and integration of murine fetal cardiomyocytes after transplantation. Circ Res (2007) 1.73
Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol (2004) 1.73
Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol (2004) 1.71
Intracellular Ca2+ oscillations drive spontaneous contractions in cardiomyocytes during early development. Proc Natl Acad Sci U S A (1999) 1.71
Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation (2000) 1.70
Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res (1999) 1.66
Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg (2005) 1.66
Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol (1997) 1.60
Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett (2007) 1.60
N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem (2003) 1.60
Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur J Cardiothorac Surg (2006) 1.59
Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation (2006) 1.52
Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng (2003) 1.44
Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol (1999) 1.42
Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev (2006) 1.35
Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci (2002) 1.31
Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol (2004) 1.24
Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc Res (1997) 1.23
The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A (2002) 1.23
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature (2012) 3.63
Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol (2008) 2.04
Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res (2010) 2.01
Initiation and propagation of ectopic waves: insights from an in vitro model of ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2002) 1.11
Interaction between spiral and paced waves in cardiac tissue. Am J Physiol Heart Circ Physiol (2007) 1.09
Locations of ectopic beats coincide with spatial gradients of NADH in a regional model of low-flow reperfusion. Am J Physiol Heart Circ Physiol (2008) 1.03
Controlled regional hypoperfusion in Langendorff heart preparations. Physiol Meas (2008) 1.03
Genesis of ectopic waves: role of coupling, automaticity, and heterogeneity. Biophys J (2005) 1.02
Signal decomposition of transmembrane voltage-sensitive dye fluorescence using a multiresolution wavelet analysis. IEEE Trans Biomed Eng (2011) 0.98
Behavior of ectopic surface: effects of beta-adrenergic stimulation and uncoupling. Am J Physiol Heart Circ Physiol (2003) 0.96
"Non-trivial pursuit of physiology". Adv Physiol Educ (2005) 0.90
Clinically relevant concentrations of di (2-ethylhexyl) phthalate (DEHP) uncouple cardiac syncytium. Toxicol Appl Pharmacol (2009) 0.90
Properties of blebbistatin for cardiac optical mapping and other imaging applications. Pflugers Arch (2012) 0.90
Use of endogenous NADH fluorescence for real-time in situ visualization of epicardial radiofrequency ablation lesions and gaps. Am J Physiol Heart Circ Physiol (2012) 0.85
Bisphenol A exposure and cardiac electrical conduction in excised rat hearts. Environ Health Perspect (2014) 0.84
Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. Toxicology (2010) 0.84
Phthalate exposure changes the metabolic profile of cardiac muscle cells. Environ Health Perspect (2012) 0.83
Development of an undergraduate pharmacogenomics curriculum. Pharmacogenomics (2009) 0.82
Immunological barriers to stem-cell based cardiac repair. Stem Cell Rev (2011) 0.81
Anthracycline-induced phospholipase A2 inhibition. Cardiovasc Toxicol (2007) 0.81
Formation of cardiac fibers in Matrigel matrix. Biotechniques (2008) 0.81
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity. Cancer Res (2003) 0.80
Downregulation of beta-microglobulin to diminish T-lymphocyte lysis of non-syngeneic cell sources of engineered heart tissue constructs. Biomed Mater (2015) 0.79
Multiple injury approach and its use for toxicity studies. Cardiovasc Toxicol (2004) 0.78
Effects of N-cadherin overexpression on the adhesion properties of embryonic stem cells. Cell Adh Migr (2009) 0.78
Preprocessing of fluoresced transmembrane potential signals for cardiac optical mapping. Conf Proc IEEE Eng Med Biol Soc (2011) 0.76
The anthracyclines: when good things go bad. Cardiovasc Toxicol (2007) 0.75